Fundz

Fundz Deep Dive

Everything you need to win US Medical Innovations — in one platform.

Who to reach, what to say, and why now on US Medical Innovations — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on US Medical Innovations — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Us Medical Innovations Raises $10.2 M In Private Placement

PRIVATESep 21, 2022over 3 years ago

Amount Raised

$10.2 Million

Takoma ParkManufacturingBiotechnologyHealth CareMedical Device

Description

US Medical Innovations, LLC (USMI), a subsidiary of US Patent Innovations, LLC, announced today it has secured a $10.2 million private placement deal from multiple sources including existing partners and new investors. USMI will be using these funds to ramp-up manufacturing of its newly-released Canady Plasma® XL-1000 SMART Electrosurgical Generator (XL-1000) and support the development and release of its Canady HeliosTM Cold Plasma Generator (CHCP) and robotic delivery system for the selective treatment of cancer.

Company Information

Company

US Medical Innovations

Location

Carroll Avenue

Takoma Park, Maryland, United States

About

US Medical Innovations, LLC (USMI) is a private U.S. biomedical device company and wholly-owned subsidiary of US Patent Innovations, LLC. USMI’s focus is developing advanced innovative affordable plasma and robotic electrosurgical devices and striving to develop innovative devices in the field of plasma technology for the eradication of cancer.

Predictive Intelligence
Strategic

ML-powered predictions for US Medical Innovations's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching US Medical Innovations? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan